TITLE

Immunotherapy with Diphenylcyclopropenone of Recalcitrant Warts: A Retrospective Analysis

AUTHOR(S)
Haedersdal, Merete; Selvaag, Edgar; Petersen, Carsten Sand
PUB. DATE
May 2000
SOURCE
Acta Dermato-Venereologica;May2000, Vol. 80 Issue 3, p217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a retrospective analysis of immunotherapy with diphenylcyclopropenone (DCP) treatment of recalcitrant warts. Presentation of patients infected of the disease treated by DCP; Side effects of the DCP treatment; Percentage of cure rate in patients.
ACCESSION #
3893288

 

Related Articles

  • A Guide to Immunotherapy of Genital Warts: Focus on Interferon and Imiquimod. Czelusta, A.J.; Evans, T.; Arany, I.; Tyring, S.K. // BioDrugs;1999, Vol. 11 Issue 5, p319 

    Genital warts affect at least 1% of sexually active adults. Current therapies are inadequate because they are often painful, may fail to prevent recurrence and transmission of warts, and usually require either surgery or at least application by a physician. Investigation of immunotherapy for...

  • A new tool for treatment of plantar warts. Kuritzky, Louis // Neurology Alert;Sep2010 Primary Care, p18 

    The article discusses research on the use of intralesional immunotherapy to treat plantar warts, by H. Gamil and colleagues, published in the 2010 issue of the "Journal of the American Academy of Dermatology."

  • Intralesional immunotherapy for the management of warts. Chandrashekar, Laxmisha // Indian Journal of Dermatology, Venereology & Leprology;May/Jun2011, Vol. 77 Issue 3, p261 

    The author reflects on the importance of intralesional immunotherapy to treat warts. The author states that the therapy is associated with the production of Th1 cytokines which activate cytotoxic and natural killer cells to eradicate human papillomavirus (HPV) infection. The author mentions that...

  • Immunotherapy for warts. Hilton, Lisette // Dermatology Times;Jul2007, Vol. 28 Issue 7, p40 

    The article reports on the destructive methods of warts treatment. Sandy Johnson, assistant clinical professor from the department of dermatology at the University of Arkansas in Little Rock, Arkansas, said that immunotherapy recognizes the virus as abnormal, where the body can fight it off...

  • Candida, mumps antigens successfully clear warts. Guttman, Cheryl // Dermatology Times;Sep2000, Vol. 21 Issue 9, p31 

    Reports on studies which found that immunotherapy with intralesional injection of mumps or Candida antigens maybe safe, effective and economical treatments for warts. Results of independent studies by Sandra Marchese-Johnson and Robert J. Signore; Open-label prospective comparison of...

  • Candida albicans wart Tx compares well. Bowser, Andrew // Dermatology Times;Oct2001, Vol. 22 Issue 10, p20 

    Reports the use of Candida albicans as intralesional immunotherapy for warts in Anaheim, California. Efficacy for warts removal; Cost of Candida injections; Availability of C. albicans allergenic extract from Greer Laboratories Inc.

  • Whittling away at warts. Hilton, Lisette // Dermatology Times;Oct2007, Vol. 28 Issue 10, p48 

    The article focuses on the new approaches for the treatment warts. It is stated that gold standard destructive methods for treating warts are giving way to modern approaches that recruit the immune system of the body to fight the lesions. In patients who were treated with immunotherapy in wart,...

  • IMMUNOTHERAPY FOR HPV: WHAT IS NEEDED AND WHY. Frazer, Ian // Infectious Diseases in Obstetrics & Gynecology;2006, Vol. 2006, p14 

    Preventing cervical cancer The only approach to preventing the consequences of persistent HPV infection currently widely available involves treatment following early detection of CIN. This requires regular screening using Pap smears, visual inspection, and/or HPV testing, followed by destructive...

  • Clinical Dermatology.  // Current Medical Literature: Dermatology;2013, Vol. 18 Issue 4, p93 

    The article discusses various research papers related to dermatology. Some of them are "Thickness of Superficial Basal Cell Carcinoma (sBCC) Predicts Imiquimod Efficacy: A Proposal for a Thickness-Based Definition of sBCC," by K.M. McKay and colleagues, "Propranolol-Resistant Infantile...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics